Necrotizing enterocolitis in neonates receiving octreotide for the management of congenital hyperinsulinism

Bruining, 1986, Normalization of glucose homeostasis by a long-acting somatostatin analog SMS 201-995 in a newborn with nesidioblastosis, Acta Endocrinol Suppl, 279, 334, 10.1530/acta.0.112S334

Hall, 1973, Action of growth-hormone-release inhibitory hormone in healthy men and in acromegaly, Lancet, 2, 581, 10.1016/S0140-6736(73)92413-6

Grozinsky-Glasberg, 2008, Long acting somatostatin analogues are an effective treatment for type 1 gastric carcinoid tumors., Eur J Endocrinol, 159, 475, 10.1530/EJE-08-0420

Reynaert, 2003, Pharmacological rationale for the use of somatostatin and analogues in portal hypertension, Aliment Pharmacol Ther, 18, 375, 10.1046/j.1365-2036.2003.01657.x

Draus, 2006, Enterocutaneous fistula: are treatments improving?, Surgery, 140, 570, 10.1016/j.surg.2006.07.003

Helin, 2006, Octreotide therapy for chylothorax in infants and children: a brief review, Pediatr Crit Care Med, 7, 576, 10.1097/01.PCC.0000235256.00265.C8

Van Keimpema, 2008, Somatostatin analogues reduce liver volume in polycystic liver disease, Gut, 57, 1338, 10.1136/gut.2008.155721

Vezzosi, 2005, Octreotide in insulinoma patients: efficacy on hypoglycemia, relationships with octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodies, Eur J Endocrinol, 152, 757, 10.1530/eje.1.01901

Tydén, 1979, Circulatory effects of somatostatin in anesthetized man, Acta Chir Scand, 145, 443

Keller, 1979, Dosage dependence of the effect of somatostatin on human splanchnic blood flow, Schweiz Med Wochenschr, 109, 595

Wahren, 1986, The influence of a long-acting somatostatin analogue on splanchnic haemodynamics and metabolism in healthy subjects and patients with liver cirrhosis, Scand J Gastroenterol Suppl, 119, 103, 10.3109/00365528609087437

Eriksson, 1987, Intravenous and subcutaneous administration of a long-acting somatostatin analogue: effects on glucose metabolism and splanchnic haemodynamics in healthy subjects, Scand J Gastroenterol, 22, 919, 10.3109/00365528708991936

Cooper, 1991, Fasting and post-prandial splanchnic blood flow is reduced by a somatostatin analogue (octreotide) in man, Clin Sci, 81, 169, 10.1042/cs0810169

Mccormick, 1993, Superior mesenteric artery blood flow in man measured with intra-arterial Doppler catheters: effect of octreotide, J Hepatol, 17, 20, 10.1016/S0168-8278(05)80516-1

Schiedermaier, 1999, Effects of different octreotide dosages on splanchnic hemodynamics and glucagon in healthy volunteers, Digestion, 60, 132, 10.1159/000007638

Nowicki, 2005, Ischemia and necrotizing enterocolitis: where, when, and how, Semin Pediatr Surg, 14, 152, 10.1053/j.sempedsurg.2005.05.003

Lin, 2008, Necrotizing enterocolitis: recent scientific advances in pathophysiology and prevention, Semin Perinatol, 32, 70, 10.1053/j.semperi.2008.01.004

Ferry, 2000, Calcium-stimulated insulin increase in diffuse and focal forms of congenital hyperinsulinism, J Pediatr, 137, 239, 10.1067/mpd.2000.107386

Hardy, 2007, Diagnosis and localization of focal congenital hyperinsulinism by 18F-fluorodopa PET scan, J Pediatr, 150, 140, 10.1016/j.jpeds.2006.08.028

Reck-Burneo, 2008, Is octreotide a risk factor in necrotizing enterocolitis?, J Pediatr Surg, 43, 1209, 10.1016/j.jpedsurg.2008.02.062

Cushing, 1910, The Pituitary Body and Its Disorders

Brazeau, 1973, Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone, Science, 179, 77, 10.1126/science.179.4068.77

Alberti, 1973, Inhibition of insulin secretion by somatostatin, Lancet, 2, 1299, 10.1016/S0140-6736(73)92873-0

Torrecillas, 1999, Mechanisms involved in the somatostatin-induced contraction of vascular smooth muscle cells, Peptides, 20, 929, 10.1016/S0196-9781(99)00083-2

Curtis, 2000, Somatostatin receptor subtype expression and function in human vascular tissue, Am J Physiol Heart Circ Physiol, 278, H1815, 10.1152/ajpheart.2000.278.6.H1815

Chatila, 2000, Local arterial vasoconstriction induced by octreotide in patients with cirrhosis, Hepatology, 31, 572, 10.1002/hep.510310304

Dimech, 1995, Somatostatin-induced contraction of human isolated saphenous vein involves sst2 receptor-mediated activation of L-type calcium channels, J Cardiovasc Pharmacol, 26, 721, 10.1097/00005344-199511000-00008

Reynaert, 2003, Pharmacological rationale for the use of somatostatin and analogues in portal hypertension, Aliment Pharmacol Ther, 18, 375, 10.1046/j.1365-2036.2003.01657.x

Henry, 2008, Neonatal necrotizing enterocolitis, Semin Pediatr Surg, 17, 98, 10.1053/j.sempedsurg.2008.02.005

Mohseni-Bod, 2004, Somatostatin analog (octreotide) in management of neonatal postoperative chylothorax: is it safe?, Pediatr Crit Care Med, 5, 356, 10.1097/01.PCC.0000123552.36127.22

Austin, 2008, Life-threatening hyperkalemia following partial pancreatectomy for neonatal hyperinsulinism, Pediatr Crit Care Med, 9, e17, 10.1097/PCC.0b013e3181728c82

32.http://www.fda.gov/ohrms/dockets/ac/07/slides/2007-4295s_04_sandostatin%20slides.ppt.